4.4 Article

Inflammation biomarkers IL-6 and IL-10 may improve the diagnostic and prognostic accuracy of currently authorized traumatic brain injury tools

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Extracellular vesicle-associated cytokines in sport-related concussion

Timothy B. Meier et al.

Summary: The study reveals that EV-associated cytokines are significantly increased following acute concussion and may serve as potential biomarkers for concussion.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Article Emergency Medicine

Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury

Pia Koivikko et al.

Summary: The study found that levels of biomarkers in patients with mTBI were significantly lower than in patients with moTBI and sTBI, but they were unable to distinguish mTBI patients from orthopaedic controls when used alone or in combination.

EMERGENCY MEDICINE JOURNAL (2022)

Review Clinical Neurology

S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy

Michael Amoo et al.

Summary: S100B showed optimal sensitivity and specificity at a threshold of 0.72 μg/L, while GFAP demonstrated 71% sensitivity and specificity at 626 pg/mL, with sensitivity peaking at 93% at 22 pg/mL. Further investigation is needed to explore the potential advantages of GFAP in the screening of mild TBI.

NEUROSURGICAL REVIEW (2022)

Article Biochemistry & Molecular Biology

Interleukin-8: An evolving chemokine

Kouji Matsushima et al.

Summary: This article introduces the research history and related findings of interleukin-8 (IL-8), including the role of IL-8 in inflammation and cancer, as well as its potential as a therapeutic target.

CYTOKINE (2022)

Article Psychiatry

Plasma biomarkers associated with deployment trauma and its consequences in post-9/11 era veterans: initial findings from the TRACTS longitudinal cohort

Meghan E. Pierce et al.

Summary: This study explored the relationships between plasma biomarkers, clinical, and medical comorbidities in a sample of post-9/11 veterans. The findings suggest that close blast exposure is associated with increased inflammation and decreased GFAP levels, which may be related to deployment-related psychopathology.

TRANSLATIONAL PSYCHIATRY (2022)

Review Clinical Neurology

GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask

Damir Janigro et al.

Summary: Traumatic brain injury is a major global health issue with significant consequences. Early diagnosis of TBI through testing peripheral fluids has been the focus of research, leading to the development of clinical tools. However, unresolved issues still exist and further research and improvements are needed.

FRONTIERS IN NEUROLOGY (2022)

Article Neurosciences

Prediction of early prognosis after traumatic brain injury by multifactor model

Bocheng Yang et al.

Summary: This study aimed to design a model for predicting the early prognosis of traumatic brain injury (TBI) patients using parameters that can be quickly obtained in emergency conditions. The results showed that age, Glasgow coma scale score, Apolipoprotein E genotype, damage area, serum C-reactive protein and interleukin-8 levels, and Marshall computed tomography score were associated with the early prognosis of TBI patients. The prediction models based on these parameters provided a reliable and rapid method for evaluating and predicting the early prognosis of TBI patients.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

Article Cell Biology

Exosomes derived from bone marrow mesenchymal stem cells inhibit neuroinflammation after traumatic brain injury

Liang Wen et al.

Summary: Exosomes derived from bone marrow mesenchymal stem cells can inhibit neuroinflammation by regulating microglial phenotypes and promoting nerve injury repair. This study found that these exosomes can promote the polarization of activated BV2 microglia to their anti-inflammatory phenotype and inhibit the expression of proinflammatory cytokines. Moreover, the exosomes reduced cell apoptosis and neuroinflammation, and promoted microglial transformation to the anti-inflammatory phenotype when injected into the tail vein. Additionally, miR181b was found to be actively involved in this process by regulating the interleukin 10/STAT3 pathway.

NEURAL REGENERATION RESEARCH (2022)

Review Clinical Neurology

Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review

Setthasorn Zhi Yang Ooi et al.

Summary: Traumatic brain injury is a major cause of mortality and morbidity worldwide, and there are currently no early biomarkers for prognosis in routine clinical use. This study suggests that interleukin-6 (IL-6) may serve as a useful biomarker for predicting clinical outcomes in TBI.

NEUROSURGICAL REVIEW (2022)

Review Medicine, General & Internal

Advances in Traumatic Brain Injury Biomarkers

Kengo Nishimura et al.

Summary: Traumatic brain injury (TBI) is a significant cause of disability worldwide. Current diagnostic methods and prognosis for TBI are inadequate. After 16 years of research, two brain-specific protein biomarkers have been approved by the FDA as blood-based indicators for TBI diagnosis.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Critical Care Medicine

Interleukin-8 Predicts Fatigue at 12 Months Post-Injury in Children with Traumatic Brain Injury

Alison Crichton et al.

Summary: This study aimed to determine whether persisting fatigue in children with traumatic brain injury could be predicted by serum biomarker concentrations, particularly IL-8. The results showed that IL-8 was the best serum biomarker for estimating the likelihood of children experiencing fatigue at 12 months post-injury, and significantly improved predictive models of fatigue based on severity.

JOURNAL OF NEUROTRAUMA (2021)

Article Critical Care Medicine

Early versus Late Profiles of Inflammatory Cytokines after Mild Traumatic Brain Injury and Their Association with Neuropsychological Outcomes

Aditya Vedantam et al.

Summary: This study explores the profile of plasma inflammatory cytokines in mTBI patients and their associations with neuropsychological outcomes. The results suggest that plasma cytokine levels post-injury are significantly associated with early and late post-concussive symptoms, PTSD, and depression scores after mTBI, highlighting the potential role of inflammation in the pathophysiology of post-traumatic symptoms.

JOURNAL OF NEUROTRAUMA (2021)

Article Multidisciplinary Sciences

M-CSF, IL-6, and TGF-β promote generation of a new subset of tissue repair macrophage for traumatic brain injury recovery

Zhiqi Li et al.

Summary: TBI can lead to high mortality rate, and patients with better outcomes have higher concentrations of M6T. Treatment with M6T can accelerate tissue repair and improve neurological function, offering a potential therapeutic strategy for TBI.

SCIENCE ADVANCES (2021)

Article Biochemistry & Molecular Biology

Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid

Johann Zwirner et al.

Summary: This study investigated a combination of body fluid biomarkers to increase the accuracy of biochemical TBI detection, and identified IL-6 and GFAP in CSF as the most accurate biomarker combination for diagnosing acute lethal TBIs. The high inter-individual correlations of biomarkers may aid in estimating the CSF concentration of unknown biomarkers for forensic biochemistry analysis.

BIOMOLECULES (2021)

Review Oncology

Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues

Daniel B. Hier et al.

Summary: Unresolved issues related to blood biomarkers after mild traumatic brain injury (mTBI) are mainly focused on the pathways of biomarkers entering and exiting the blood, the kinetics of blood biomarkers, and the predictive capacity of blood biomarkers after mTBI. Further research is needed to address these issues.

BIOMARKER RESEARCH (2021)

Review Medicine, General & Internal

Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury

Kevin K. W. Wang et al.

Summary: Traumatic brain injury (TBI) is a major cause of mortality and morbidity across all ages, yet there is no FDA-approved drug for treatment. The heterogeneity and complexity of TBI make accurate assessment and prediction challenging. Biomarkers such as ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein have been identified to improve diagnostic accuracy, especially in mild TBI cases.

ACUTE MEDICINE & SURGERY (2021)

Review Medicine, General & Internal

Systematic Review of Serum Biomarkers in Traumatic Brain Injury

Khashayar Mozaffari et al.

Summary: TBI is a major cause of trauma-related deaths and disability, characterized by an inflammatory process in secondary brain injury progression. This study comprehensively evaluates serum biomarkers for TBI, highlighting GFAP, S100, and NSE as prominent markers, suggesting noninvasive panels should include these three for sensitivity and specificity optimization.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Article Medicine, General & Internal

Traumatic Brain Injury An Overview of Epidemiology, Pathophysiology, and Medical Management

Allison Capizzi et al.

MEDICAL CLINICS OF NORTH AMERICA (2020)

Article Clinical Neurology

A Prospective Study of Acute Blood-Based Biomarkers for Sport-Related Concussion

Timothy B. Meier et al.

ANNALS OF NEUROLOGY (2020)

Article Clinical Neurology

Interleukin-6 is associated with acute concussion in military combat personnel

Katie A. Edwards et al.

BMC NEUROLOGY (2020)

Review Immunology

Historical overview of the interleukin-6 family cytokine

Sujin Kang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Clinical Neurology

COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation

Duraisamy Kempuraj et al.

NEUROSCIENTIST (2020)

Article Clinical Neurology

Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury

Hilaire J. Thompson et al.

JOURNAL OF HEAD TRAUMA REHABILITATION (2020)

Article Emergency Medicine

Is IL-8 level an indicator of clinical and radiological status of traumatic brain injury?

Omer Polat et al.

ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY (2019)

Article Cell Biology

Interleukin-6 Family Cytokines

Stefan Rose-John

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Review Biochemistry & Molecular Biology

Traumatic brain injury: classification, models, and markers

Dema Najem et al.

BIOCHEMISTRY AND CELL BIOLOGY (2018)

Article Medical Laboratory Technology

Serum S100A12 as a prognostic biomarker of severe traumatic brain injury

Ma-Jing Feng et al.

CLINICA CHIMICA ACTA (2018)

Review Pathology

An update on diagnostic and prognostic biomarkers for traumatic brain injury

Kevin K. Wang et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)

Article Medicine, Legal

Acute phase response after fatal traumatic brain injury

Benjamin Ondruschka et al.

INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2018)

Review Clinical Neurology

Traumatic brain injury: sex, gender and intersecting vulnerabilities

Tatyana Mollayeva et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Cell Biology

Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics

Matthew L. Pearn et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)

Review Neurosciences

Neuroimmunology of Traumatic Brain Injury: Time for a ParadigmShift

Yasir N. Jassam et al.

NEURON (2017)

Article Rehabilitation

Pathophysiology of Traumatic Brain Injury

Kirsty J. Dixon

PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA (2017)

Article Surgery

Acute Management of Traumatic Brain Injury

Michael A. Vella et al.

SURGICAL CLINICS OF NORTH AMERICA (2017)

Review Clinical Neurology

Role of interleukin-10 in Acute Brain injuries

Joshua M. Garcia et al.

FRONTIERS IN NEUROLOGY (2017)

Article Mathematical & Computational Biology

Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach

Ilker Unal

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2017)

Article Immunology

Moderate blast exposure results in increased IL-6 and TNFα in peripheral blood

Jessica Gill et al.

BRAIN BEHAVIOR AND IMMUNITY (2017)

Review Cell & Tissue Engineering

Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors

Michael Galgano et al.

CELL TRANSPLANTATION (2017)

Article Medical Laboratory Technology

Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury

Ding-Bo Yang et al.

CLINICA CHIMICA ACTA (2017)

Review Pharmacology & Pharmacy

The contribution of astrocytes and microglia to traumatic brain injury

Ila P. Karve et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Clinical Neurology

Pathophysiology of Traumatic Brain Injury

Melissa J. McGinn et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2016)

Article Immunology

Emerging Roles for the Immune System in Traumatic Brain Injury

Celia A. Mckee et al.

FRONTIERS IN IMMUNOLOGY (2016)

Review Clinical Neurology

Post-Traumatic Brain Injury: Genetic Susceptibility to Outcome

Jennilee Davidson et al.

NEUROSCIENTIST (2015)

Article Multidisciplinary Sciences

Oxidative Burst of Circulating Neutrophils Following Traumatic Brain Injury in Human

Yiliu Liao et al.

PLOS ONE (2013)

Review Clinical Neurology

The role of markers of inflammation in traumatic brain injury

Thomas Woodcock et al.

FRONTIERS IN NEUROLOGY (2013)

Article Endocrinology & Metabolism

Interleukin-10 Is an Independent Biomarker of Severe Traumatic Brain Injury Prognosis

Flavia Mahatma Schneider Soares et al.

NEUROIMMUNOMODULATION (2012)

Article Rehabilitation

Position Statement: Definition of Traumatic Brain Injury

David K. Menon et al.

ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2010)

Article Immunology

Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury

Georgene W. Hergenroeder et al.

JOURNAL OF NEUROINFLAMMATION (2010)

Review Chemistry, Medicinal

Serum Biochemical Markers of Brain Injury

S. Korfias et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)

Article Critical Care Medicine

Serum IL-8 and MCP-1 Concentration Do Not Identify Patients With Enlarging Contusions After Traumatic Brain Injury

Jonathan Rhodes et al.

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2009)

Article Clinical Neurology

Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children

Antonio Chiaretti et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2008)

Article Medicine, General & Internal

Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury

Aleksandar Gopcevic et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Critical Care Medicine

Serum S-100B protein monitoring in patients with severe traumatic brain injury

Stefanos Korfias et al.

INTENSIVE CARE MEDICINE (2007)

Review Biochemistry & Molecular Biology

Serum S-100B protein as a biochemical marker of brain injury: A review of current concepts

S. Korfias et al.

CURRENT MEDICINAL CHEMISTRY (2006)

Article Critical Care Medicine

Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients

C Woiciechowsky et al.

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2002)

Article Critical Care Medicine

Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury

MJ Whalen et al.

CRITICAL CARE MEDICINE (2000)